Navigation Links
MEI Pharma Announces Pricing of Public Offering of Common Stock
Date:10/25/2013

the acquisition of PWT143, a highly selective PI3-kinase delta inhibitor. For more information, go to www.meipharma.com.

Under U.S. law, a new drug cannot be marketed until it has been investigated in clinical trials and approved by the FDA as being safe and effective for the intended use. Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. You should be aware that our actual results could differ materially from those contained in the forward-looking statements, which are based on management's current expectations and are subject to a number of risks and uncertainties, including, but not limited to, our failure to successfully commercialize our product candidates; costs and delays in the development and/or FDA approval, or the failure to obtain such approval, of our product candidates; uncertainties or differences in interpretation in clinical trial results; our inability to maintain or enter into, and the risks resulting from our dependence upon, collaboration or contractual arrangements necessary for the development, manufacture, commercialization, marketing, sales and distribution of any products; competitive factors; our inability to protect our patents or proprietary rights and obtain necessary rights to third party patents and intellectual property to operate our business; our inability to operate our business without infringing the patents and proprietary rights of others; general economic conditions; the failure of any products to gain market acceptance; our inability to obtain any additional required financing; technological changes; government regulation; changes in industry practice; and one-time events. We do not intend to update any of these factors or to publicly announce the results of any revisions to these forward-looking statements.<
'/>"/>

SOURCE MEI Pharma, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
6. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
9. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
10. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
11. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... June 29, 2015 Research ... the "Pharmaceutical Grade Sodium Chloride Market by Applications, ... report to their offering. The pharmaceutical ... CAGR of 6.9% between 2014 and 2019 in terms ... 690 KT by 2019. The report on ...
(Date:7/6/2015)... July 6, 2015 Moerae Matrix, a ... therapeutics that target inflammation and fibrosis, today announced ... PhD, as Chief Medical Officer. ... strategy and programs, which include a pipeline of ... fibrotic conditions.  Bill is an accomplished strategist and ...
(Date:7/6/2015)... 6, 2015 Celtaxsys, Inc., a clinical stage ... with rare and orphan inflammatory disease indications, announced today ... and Drug Administration (FDA) to begin a Phase 2 ... in adult CF patients in the US. The regulatory ... will be filed soon after. This groundbreaking ...
Breaking Medicine Technology:Global Pharmaceutical Grade Sodium Chloride Market Report 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 3Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3
... Inc. (NYSE: SMA ), a leading independent ... and other medical markets, announced a new management reporting ... to strengthen quality and customer service.  The Company,s implant, ... Thomas J. Sullivan, President and Chief Executive Officer. ...
... Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care ... its financial results for the fourth quarter and fiscal year ... 4:15 p.m. ET on Thursday, April 28, 2011.  The Company ... year 2011 after the market closes on Thursday, April 28, ...
Cached Medicine Technology:Symmetry Medical Centralizes Businesses Under CEO 2Symmetry Medical Centralizes Businesses Under CEO 3Symmetry Medical Centralizes Businesses Under CEO 4
(Date:7/6/2015)... ... July 06, 2015 , ... With a new community ... with Livonia Save Our Youth and announced a new charity campaign to raise funds ... to alcohol and drug abuse. Livonia Save Our Youth is a coalition created especially ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... that Randstad Technologies selected Aspect Software Unified IP contact center solution hosted by ... selected Aspect Unified IP as its future call center platform. , Promero ...
(Date:7/6/2015)... , ... July 06, 2015 , ... The Path of ... into the economic transformation associated with the U.S. economy over the past 40 years. ... with its use. In many ways, the book is a time capsule that chronicles ...
(Date:7/5/2015)... ... July 05, 2015 , ... World Patent ... Master, a landscaping invention that effectively removes weeds without harming man and ... Scott Cooper, CEO and Creative Director of World Patent Marketing. "It is projected ...
(Date:7/4/2015)... ... July 04, 2015 , ... ... published the results of an annual member survey , detailing the most ... More recently, the group broke that raw data down into charts detailing demographic ...
Breaking Medicine News(10 mins):Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 2Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 3Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 3Health News:New Book Brings Reveals The Repercussions Associated With The Global Economy 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 4Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 5Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 2Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 3
... one in 500 Swedes carry a genetic mutation which can ... lifestyle changes, but quality of life can be maintained with ... the Sahlgrenska Academy at the University of Gothenburg, Sweden. ... children and adolescents is the heart muscle disease hypertrophic cardiomyopathy. ...
... its inception in 1998, TCAG has provided world-leading infrastructure ... of genomic disciplines, from human health to agriculture, food, ... based at The Hospital for Sick Children, is located ... including:, Gene and genome sequencing Microarrays and genotyping ...
... 1 (HealthDay News) -- Loneliness can be harmful to a ... Researchers examined levels of loneliness and sleep quality among ... was socially isolated, but those who had higher loneliness scores ... often during the night and were deemed to have what ...
... By Serena Gordon HealthDay Reporter , TUESDAY, Nov. 1 ... United States dropped slightly, to 12.2 percent in 2009, from its ... March of Dimes. , But those numbers fall far short ... explained Dr. Jennifer Howse, president of the March of Dimes. ...
... Island Hospital examined how the perception of roles among ... web survey with embedded interventions, the researchers were able ... patient satisfaction, while staff reported changing or reconsidering how ... published in the European Journal of Emergency Medicine ...
... people in Uganda live with HIV/AIDS, where long ... to treatment. By employing an innovative mobile-technology strategy, ... Lawson Health Research Institute, hopes to provide a ... own a mobile device. By leveraging this common ...
Cached Medicine News:Health News:Research supports broader screening for sudden cardiac death 2Health News:Loneliness Linked to Sleepless Nights 2Health News: U.S. Preterm Birth Rate Down Slightly 2Health News: U.S. Preterm Birth Rate Down Slightly 3Health News:How staff perceptions of their roles impact patients experience in the emergency department 2Health News:How staff perceptions of their roles impact patients experience in the emergency department 3
... For immobilization following shoulder fusion, dislocation, ... brace allows the shoulder to be ... rotation. Following brachial plexus injury this ... further stretch during the healing process ...
Unique V-lock strapping system prevents roll and shifting to provide secure shoulder immobilization...
Shoulder Subluxation Inhibitor (SSI) is an ideal bracing system to keep athletes on the field by reducing the risk of shoulder injury. The SSI is the only brace that allows TOTAL ANTERIOR RANGE OR MO...
... Bird and Cronin, ... manufacturer of Patient Footwear, ... Patient Care Products. Our ... highest quality and available ...
Medicine Products: